The DOI matches its Crossref record; 360 of the 360 references it cites were found in a registry or an index.
The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
Open accessAbstract
With cardiovascular disease (CVD) being a primary source of global morbidity and mortality, it is crucial that we understand the molecular pathophysiological mechanisms at play. Recently, numerous pro-inflammatory cytokines have been linked to several different CVDs, which are now often considered an adversely pro-inflammatory state. These cytokines most notably include interleukin-6 (IL-6),tumor necrosis factor (TNF)α, and the interleukin-1 (IL-1) family, amongst others. Not only does inflammation have intricate and complex interactions with pathophysiological processes such as oxidative stress and calcium mishandling, but it also plays a role in the balance between tissue repair and destruction. In this regard, pre-clinical and clinical evidence has clearly demonstrated the involvement and dynamic nature of pro-inflammatory cytokines in many heart conditions; however, the clinical utility of the findings so far remains unclear. Whether these cytokines can serve as markers or risk predictors of disease states or act as potential therapeutic targets, further extensive research is needed to fully understand the complex network of interactions that these molecules encompass in the context of heart disease. This review will highlight the significant advances in our understanding of the contributions of pro-inflammatory cytokines in CVDs, including ischemic heart disease (atherosclerosis, thrombosis, acute myocardial infarction, and ischemia-reperfusion injury), cardiac remodeling (hypertension, cardiac hypertrophy, cardiac fibrosis, cardiac apoptosis, and heart failure), different cardiomyopathies as well as ventricular arrhythmias and atrial fibrillation. In addition, this article is focused on discussing the shortcomings in both pathological and therapeutic aspects of pro-inflammatory cytokines in CVD that still need to be addressed by future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wei, H., Bedja, D., Koitabashi, N., Xing, D., Chen, J., Fox-Talbot, K., Rouf, R., Chen, S., Steenbergen, C., Harmon, J. W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202081109 · Cited by 132
RetractedHuo, S., Shi, W., Ma, H., Yan, D., Luo, P., Guo, J., Li, C., Lin, J., Zhang, C., Li, S., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6699054 · Cited by 74
RetractedAntiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Cytokines, Inflammation, and Pain
Zhang, J.-M., & An, J. (2007) · International Anesthesiology Clinics · doi:10.1097/aia.0b013e318034194e · Cited by 2,945
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248 · cited 1×
“Additionally, the endogenously produced IL-1 receptor antagonist (IL-1Ra), commercially known as anakinra, blocks IL-1 α and IL-1 β ’s biological activity by binding to their receptor to prevent their association [19].”
BackgroundDesmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?
Hussain, T., Tan, B., Yin, Y., Blachier, F., Tossou, M. C. B., & Rahu, N. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7432797 · Cited by 2,082
Overview of the IL ‐1 family in innate inflammation and acquired immunity
Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736
Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights
Kornej, J., Börschel, C. S., Benjamin, E. J., & Schnabel, R. B. (2020) · Circulation Research · doi:10.1161/circresaha.120.316340 · Cited by 1,516
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Role of oxidative stress in cardiovascular diseases
Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00002 · Cited by 1,467
Self-citationAn overview of the immune system
Parkin, J., & Cohen, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04904-7 · Cited by 1,460
Maron, B. J., & Maron, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60397-3 · Cited by 1,231
Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00589-7 · Cited by 1,211
Inflammation and the pathogenesis of atrial fibrillation
Hu, Y.-F., Chen, Y.-J., Lin, Y.-J., & Chen, S.-A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.2 · Cited by 1,089
Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040
Frostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934
The Inflammatory Response to Cell Death
Rock, K. L., & Kono, H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151456 · Cited by 912
TGF-β: A Master of All T Cell Trades
Li, M. O., & Flavell, R. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.025 · Cited by 893
Kawaguchi, M., Takahashi, M., Hata, T., Kashima, Y., Usui, F., Morimoto, H., Izawa, A., Takahashi, Y., Masumoto, J., Koyama, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.982777 · Cited by 884
Borish, L. C., & Steinke, J. W. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.108 · Cited by 879
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Marijon, E., Mirabel, M., Celermajer, D. S., & Jouven, X. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61171-9 · Cited by 856
Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction
Madhur, M. S., Lob, H. E., McCann, L. A., Iwakura, Y., Blinder, Y., Guzik, T. J., & Harrison, D. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145094 · Cited by 827
Tolerance, not immunity, crucially depends on IL-2
Malek, T. R., & Bayer, A. L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1435 · Cited by 820
Status of myocardial antioxidants in ischemia–reperfusion injury
Dhalla, N. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00078-x · Cited by 802
Self-citationRidker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
IL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters
Del Giudice, M., & Gangestad, S. W. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.013 · Cited by 779
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748
Detection of activated T lymphocytes in the human atherosclerotic plaque.
Hansson, G. K., Holm, J., & Jonasson, L. (1989) · Europe PMC (PubMed Central) · Cited by 744
Elevated Levels of Interleukin-6 in Unstable Angina
Biasucci, L. M., Vitelli, A., Liuzzo, G., Altamura, S., Caligiuri, G., Monaco, C., Rebuzzi, A. G., Ciliberto, G., & Maseri, A. (1996) · Circulation · doi:10.1161/01.cir.94.5.874 · Cited by 738
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Abbate, A., Toldo, S., Marchetti, C., Kron, J., Van Tassell, B. W., & Dinarello, C. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.315937 · Cited by 730
Blood Pressure and Inflammation in Apparently Healthy Men
Chae, C. U., Lee, R. T., Rifai, N., & Ridker, P. M. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.399 · Cited by 716
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Steven, S., Frenis, K., Oelze, M., Kalinovic, S., Kuntic, M., Bayo Jimenez, M. T., Vujacic-Mirski, K., Helmstädter, J., Kröller-Schön, S., Münzel, T., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7092151 · Cited by 708
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Ridker, P. M., & Rane, M. (2021) · Circulation Research · doi:10.1161/circresaha.121.319077 · Cited by 691
Innate Immunity and the Failing Heart: The Cytokine Hypothesis Revisited
Mann, D. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.302317 · Cited by 689
Li, H., Cybulsky, M. I., Gimbrone, M. A., & Libby, P. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.197 · Cited by 689
Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity
Sanjabi, S., Zenewicz, L. A., Kamanaka, M., & Flavell, R. A. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.04.008 · Cited by 661
IL-11 is a crucial determinant of cardiovascular fibrosis
Schafer, S., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Moreno-Moral, A., DeLaughter, D. M., Ng, B., Patone, G., Chow, K., Khin, E., et al. (2017) · Nature · doi:10.1038/nature24676 · Cited by 639
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
Libby, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.028 · Cited by 619
Kuwahara, F., Kai, H., Tokuda, K., Kai, M., Takeshita, A., Egashira, K., & Imaizumi, T. (2002) · Circulation · doi:10.1161/01.cir.0000020689.12472.e0 · Cited by 609
Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α
Bryant, D., Becker, L., Richardson, J., Shelton, J., Franco, F., Peshock, R., Thompson, M., & Giroir, B. (1998) · Circulation · doi:10.1161/01.cir.97.14.1375 · Cited by 600
Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina
Blankenberg, S., Tiret, L., Bickel, C., Peetz, D., Cambien, F., Meyer, J., & Rupprecht, H. J. (2002) · Circulation · doi:10.1161/01.cir.0000020546.30940.92 · Cited by 568
Lindmark, E., Diderholm, E., Wallentin, L., & Siegbahn, A. (2001) · JAMA · doi:10.1001/jama.286.17.2107 · Cited by 556
TESTA, M., YEH, M., LEE, P., BERMAN, J. W., LEJEMTEL, T. H., FANELLI, R., & LOPERFIDO, F. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00268-9 · Cited by 540
DC isoketal-modified proteins activate T cells and promote hypertension
Kirabo, A., Fontana, V., de Faria, A. P. C., Loperena, R., Galindo, C. L., Wu, J., Bikineyeva, A. T., Dikalov, S., Xiao, L., Chen, W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74084 · Cited by 538
Increased circulating cytokines in patients with myocarditis and cardiomyopathy.
Matsumori, A., Yamada, T., Suzuki, H., Matoba, Y., & Sasayama, S. (1994) · Heart · doi:10.1136/hrt.72.6.561 · Cited by 524
Siwik, D. A., Chang, D. L.-F., & Colucci, W. S. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1259 · Cited by 517
Frangogiannis, N. G., Lindsey, M. L., Michael, L. H., Youker, K. A., Bressler, R. B., Mendoza, L. H., Spengler, R. N., Smith, C. W., & Entman, M. L. (1998) · Circulation · doi:10.1161/01.cir.98.7.699 · Cited by 511
Hirota, H., Yoshida, K., Kishimoto, T., & Taga, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4862 · Cited by 505
Libby, P., Ordovás, J. M., Auger, K. R., Robbins, A. H., Birinyi, L. K., & Dinarello, C. A. (1986) · PubMed Central · Cited by 494
Cardiac fibrosis – A short review of causes and therapeutic strategies
Hinderer, S., & Schenke-Layland, K. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.011 · Cited by 490
Biasucci, L. M., Liuzzo, G., Fantuzzi, G., Caligiuri, G., Rebuzzi, A. G., Ginnetti, F., Dinarello, C. A., & Maseri, A. (1999) · Circulation · doi:10.1161/01.cir.99.16.2079 · Cited by 485
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 480
Role of Inflammation in Atrial Fibrillation Pathophysiology and Management
Harada, M., Van Wagoner, D. R., & Nattel, S. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0138 · Cited by 473
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Ramji, D. P., & Davies, T. S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.04.003 · Cited by 469
Mach, F., Sauty, A., Iarossi, A. S., Sukhova, G. K., Neote, K., Libby, P., & Luster, A. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6993 · Cited by 464
Detection and localization of tumor necrosis factor in human atheroma
Barath, P., Fishbein, M. C., Cao, J., Berenson, J., Helfant, R. H., & Forrester, J. S. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90291-8 · Cited by 449
Teekakirikul, P., Eminaga, S., Toka, O., Alcalai, R., Wang, L., Wakimoto, H., Nayor, M., Konno, T., Gorham, J. M., Wolf, C. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42028 · Cited by 448
Fundamentals of Reperfusion Injury for the Clinical Cardiologist
Verma, S., Fedak, P. W. M., Weisel, R. D., Butany, J., Rao, V., Maitland, A., Li, R.-K., Dhillon, B., & Yau, T. M. (2002) · Circulation · doi:10.1161/01.cir.0000016602.96363.36 · Cited by 446
Basic mechanisms in heart failure: The cytokine hypothesis
Seta, Y., Shan, K., Bozkurt, B., Oral, H., & Mann, D. L. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80047-9 · Cited by 444
Interleukin-6 Exacerbates Early Atherosclerosis in Mice
Huber, S. A., Sakkinen, P., Conze, D., Hardin, N., & Tracy, R. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2364 · Cited by 443
Meléndez, G. C., McLarty, J. L., Levick, S. P., Du, Y., Janicki, J. S., & Brower, G. L. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.148635 · Cited by 442
Kurrelmeyer, K. M., Michael, L. H., Baumgarten, G., Taffet, G. E., Peschon, J. J., Sivasubramanian, N., Entman, M. L., & Mann, D. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070036297 · Cited by 440
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction
Cohen, J. B., Schrauben, S. J., Zhao, L., Basso, M. D., Cvijic, M. E., Li, Z., Yarde, M., Wang, Z., Bhattacharya, P. T., Chirinos, D. A., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.09.009 · Cited by 432
Suematsu, N., Tsutsui, H., Wen, J., Kang, D., Ikeuchi, M., Ide, T., Hayashidani, S., Shiomi, T., Kubota, T., Hamasaki, N., et al. (2003) · Circulation · doi:10.1161/01.cir.0000055318.09997.1f · Cited by 427
TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
Schultz, J. E. J., Witt, S. A., Glascock, B. J., Nieman, M. L., Reiser, P. J., Nix, S. L., Kimball, T. R., & Doetschman, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14190 · Cited by 426
Gray, M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00121-7 · Cited by 417
Mallat, Z., Corbaz, A., Scoazec, A., Graber, P., Alouani, S., Esposito, B., Humbert, Y., Chvatchko, Y., & Tedgui, A. (2001) · Circulation Research · doi:10.1161/hh1901.098735 · Cited by 407
Brucato, A., Imazio, M., Gattorno, M., Lazaros, G., Maestroni, S., Carraro, M., Finetti, M., Cumetti, D., Carobbio, A., Ruperto, N., et al. (2016) · JAMA · doi:10.1001/jama.2016.15826 · Cited by 401
Maybaum, S., Mancini, D., Xydas, S., Starling, R. C., Aaronson, K., Pagani, F. D., Miller, L. W., Margulies, K., McRee, S., Frazier, O. H., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.633180 · Cited by 399
Perturbation of the T-cell repertoire in patients with unstable angina.
Liuzzo, G., Kopecky, S. L., Frye, R. L., Fallon, W. M. O., Maseri, A., Goronzy, J. J., & Weyand, C. M. (1999) · Circulation · doi:10.1161/01.cir.100.21.2135 · Cited by 398 · cited 1×
“Patients with unstable angina showed higher numbers of CD4+ and CD8+ T-cells producing IFN-γ than patients with stable angina [126].”
BackgroundClinton, S. K., Underwood, R., Hayes, L., Sherman, M. L., Kufe, D. W., & Libby, P. (1992) · PubMed · Cited by 377
Han, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377
Cytokine-Induced Modulation of Cardiac Function
Prabhu, S. D. (2004) · Circulation Research · doi:10.1161/01.res.0000150734.79804.92 · Cited by 375
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
Elhage, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00343-2 · Cited by 373
Exercise Provides Direct Biphasic Cardioprotection via Manganese Superoxide Dismutase Activation
Yamashita, N., Hoshida, S., Otsu, K., Asahi, M., Kuzuya, T., & Hori, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1699 · Cited by 371
Irwin, M. W., Mak, S., Mann, D. L., Qu, R., Penninger, J. M., Yan, A., Dawood, F., Wen, W.-H., Shou, Z., & Liu, P. (1999) · Circulation · doi:10.1161/01.cir.99.11.1492 · Cited by 367
Exercise training modulates cytokines activity in coronary heart disease patients
Goldhammer, E., Tanchilevitch, A., Maor, I., Beniamini, Y., Rosenschein, U., & Sagiv, M. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.08.073 · Cited by 363
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
Klein, A. L., Imazio, M., Cremer, P., Brucato, A., Abbate, A., Fang, F., Insalaco, A., LeWinter, M., Lewis, B. S., Lin, D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2027892 · Cited by 358
Qiu, Z., Lei, S., Zhao, B., Wu, Y., Su, W., Liu, M., Meng, Q., Zhou, B., Leng, Y., & Xia, Z.-Y. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9743280 · Cited by 351
TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
Schultz, J. E. J., Witt, S. A., Glascock, B. J., Nieman, M. L., Reiser, P. J., Nix, S. L., Kimball, T. R., & Doetschman, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214190 · Cited by 351
Severino, P., D'Amato, A., Pucci, M., Infusino, F., Adamo, F., Birtolo, L. I., Netti, L., Montefusco, G., Chimenti, C., Lavalle, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218118 · Cited by 349
Dynamic balance of pro‐ and anti‐inflammatory signals controls disease and limits pathology
Cicchese, J. M., Evans, S., Hult, C., Joslyn, L. R., Wessler, T., Millar, J. A., Marino, S., Cilfone, N. A., Mattila, J. T., Linderman, J. J., et al. (2018) · Immunological Reviews · doi:10.1111/imr.12671 · Cited by 343
Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
Rus, H. G., Vlaicu, R., & Niculescu, F. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05968-0 · Cited by 335
Blankenberg, S., Luc, G., Ducimetière, P., Arveiler, D., Ferrières, J., Amouyel, P., Evans, A., Cambien, F., & Tiret, L. (2003) · Circulation · doi:10.1161/01.cir.0000099509.76044.a2 · Cited by 329
Role of inflammation and oxidative stress in atrial fibrillation
Li, J., Solus, J., Chen, Q., Rho, Y. H., Milne, G., Stein, C. M., & Darbar, D. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2009.12.009 · Cited by 317
Pomerantz, B. J., Reznikov, L. L., Harken, A. H., & Dinarello, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041611398 · Cited by 310
Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension
Nguyen, H., Chiasson, V. L., Chatterjee, P., Kopriva, S. E., Young, K. J., & Mitchell, B. M. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvs422 · Cited by 300
Endotoxin-induced serum factor that stimulates gamma interferon production
Nakamura, K., Okamura, H., Wada, M., Nagata, K., & Tamura, T. (1989) · Infection and Immunity · doi:10.1128/iai.57.2.590-595.1989 · Cited by 299
Mechanisms of Ca2+ Overload in Reperfused Ischemic Myocardium
Tani, M. (1990) · Annual Review of Physiology · doi:10.1146/annurev.ph.52.030190.002551 · Cited by 295
Liao, Y.-H., Xia, N., Zhou, S.-F., Tang, T.-T., Yan, X.-X., Lv, B.-J., Nie, S.-F., Wang, J., Iwakura, Y., Xiao, H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.863 · Cited by 295
Role of cytokines and inflammation in heart function during health and disease
Bartekova, M., Radosinska, J., Jelemensky, M., & Dhalla, N. S. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9716-x · Cited by 293
Self-citationShimokawa, H., Ito, A., Fukumoto, Y., Kadokami, T., Nakaike, R., Sakata, M., Takayanagi, T., Egashira, K., & Takeshita, A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118476 · Cited by 292
Programmed cell death and its role in inflammation
Yang, Y., Jiang, G., Zhang, P., & Fan, J. (2015) · Military Medical Research · doi:10.1186/s40779-015-0039-0 · Cited by 290
Buono, C., Come, C. E., Stavrakis, G., Maguire, G. F., Connelly, P. W., & Lichtman, A. H. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000059419.11002.6e · Cited by 289
Impact of Interleukin-6 on Plaque Development and Morphology in Experimental Atherosclerosis
Schieffer, B., Selle, T., Hilfiker, A., Hilfiker-Kleiner, D., Grote, K., Tietge, U. J. F., Trautwein, C., Luchtefeld, M., Schmittkamp, C., Heeneman, S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148135.08582.97 · Cited by 288
Youn, J.-C., Yu, H. T., Lim, B. J., Koh, M. J., Lee, J., Chang, D.-Y., Choi, Y. S., Lee, S.-H., Kang, S.-M., Jang, Y., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.00689 · Cited by 284
Dendritic Cell Amiloride-Sensitive Channels Mediate Sodium-Induced Inflammation and Hypertension
Barbaro, N. R., Foss, J. D., Kryshtal, D. O., Tsyba, N., Kumaresan, S., Xiao, L., Mernaugh, R. L., Itani, H. A., Loperena, R., Chen, W., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.002 · Cited by 282
Conway, D. S. G., Buggins, P., Hughes, E., & Lip, G. Y. H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.062 · Cited by 280
Sriramula, S., Haque, M., Majid, D. S. A., & Francis, J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.102152 · Cited by 278
Intracellular calcium homeostasis in cardiac myocytes.
Barry, W. H., & Bridge, J. H. (1993) · Circulation · doi:10.1161/01.cir.87.6.1806 · Cited by 276
Plasma tumour necrosis factor-α and early carotid atherosclerosis in healthy middle-aged men
Skoog, T. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2805 · Cited by 275
Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans
Itani, H. A., McMaster, W. G., Saleh, M. A., Nazarewicz, R. R., Mikolajczyk, T. P., Kaszuba, A. M., Konior, A., Prejbisz, A., Januszewicz, A., Norlander, A. E., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07237 · Cited by 271
Adamopoulos, S., Parissis, J., Karatzas, D., Kroupis, C., Georgiadis, M., Karavolias, G., Paraskevaidis, J., Koniavitou, K., Coats, A. J. S., & Kremastinos, D. T. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01795-8 · Cited by 270
Hansson, G. K., Hellstrand, M., Rymo, L., Rubbia, L., & Gabbiani, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1595 · Cited by 268
Xia, Y., Lee, K., Li, N., Corbett, D., Mendoza, L., & Frangogiannis, N. G. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0541-5 · Cited by 264
Devaux, B., Scholz, D., Hirche, A., Klovekorn, W. P., & Schaper, J. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015268 · Cited by 264
Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions
Seino, Y., Ikeda, U., Ikeda, M., Yamamoto, K., Misawa, Y., Hasegawa, T., Kano, S., & Shimada, K. (1994) · Cytokine · doi:10.1016/1043-4666(94)90013-2 · Cited by 263
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
Libby, P., Ordovas, J. M., Birinyi, L. K., Auger, K. R., & Dinarello, C. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112732 · Cited by 258
Zhang, Z., Tang, J., Song, J., Xie, M., Liu, Y., Dong, Z., Liu, X., Li, X., Zhang, M., Chen, Y., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.020 · Cited by 256
Angiotensin II hypertension is attenuated in interleukin-6 knockout mice
Lee, D. L., Sturgis, L. C., Labazi, H., Osborne, J. B., Fleming, C., Pollock, J. S., Manhiani, M., Imig, J. D., & Brands, M. W. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00708.2005 · Cited by 254
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
Sager, H. B., Heidt, T., Hulsmans, M., Dutta, P., Courties, G., Sebas, M., Wojtkiewicz, G. R., Tricot, B., Iwamoto, Y., Sun, Y., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016160 · Cited by 253
Wang, N., Tabas, I., Winchester, R., Ravalli, S., Rabbani, L. E., & Tall, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8837 · Cited by 252
The Role of the TGF-β Superfamily in Myocardial Infarction
Hanna, A., & Frangogiannis, N. G. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00140 · Cited by 251
Wu, N., Xu, B., Xiang, Y., Wu, L., Zhang, Y., Ma, X., Tong, S., Shu, M., Song, Z., Li, Y., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.078 · Cited by 247
Van Tassell, B. W., Canada, J., Carbone, S., Trankle, C., Buckley, L., Oddi Erdle, C., Abouzaki, N. A., Dixon, D., Kadariya, D., Christopher, S., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.117.004373 · Cited by 245
Wu, J., Thabet, S. R., Kirabo, A., Trott, D. W., Saleh, M. A., Xiao, L., Madhur, M. S., Chen, W., & Harrison, D. G. (2014) · Circulation Research · doi:10.1161/circresaha.114.302157 · Cited by 242
Inflammation and Cardiovascular Disease: Role of the Interleukin-1 Receptor Antagonist
Fearon, W. F., & Fearon, D. T. (2008) · Circulation · doi:10.1161/circulationaha.108.772491 · Cited by 241
Cortez, D. M., Feldman, M. D., Mummidi, S., Valente, A. J., Steffensen, B., Vincenti, M., Barnes, J. L., & Chandrasekar, B. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00928.2007 · Cited by 241
Zinman, B., Hanley, A. J. G., Harris, S. B., Kwan, J., & Fantus, I. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5405 · Cited by 239
Managing toxicities of high-dose interleukin-2.
Schwartz, R. N., Stover, L. L., & Dutcher, J. P. (2002) · PubMed · Cited by 229
Marcus, G. M., Whooley, M. A., Glidden, D. V., Pawlikowska, L., Zaroff, J. G., & Olgin, J. E. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.09.006 · Cited by 228
Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer
Amin, M. N., Siddiqui, S. A., Ibrahim, M., Hakim, M. L., Ahammed, M. S., Kabir, A., & Sultana, F. (2020) · SAGE Open Medicine · doi:10.1177/2050312120965752 · Cited by 227
Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells.
Warner, S. J., Auger, K. R., & Libby, P. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.5.1316 · Cited by 222
Everett, B. M., MacFadyen, J. G., Thuren, T., Libby, P., Glynn, R. J., & Ridker, P. M. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.011 · Cited by 220
Higashikuni, Y., Liu, W., Numata, G., Tanaka, K., Fukuda, D., Tanaka, Y., Hirata, Y., Imamura, T., Takimoto, E., Komuro, I., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.060860 · Cited by 219
Abe, I., Teshima, Y., Kondo, H., Kaku, H., Kira, S., Ikebe, Y., Saito, S., Fukui, A., Shinohara, T., Yufu, K., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.06.025 · Cited by 217
Guilherme, L., Cury, P., Demarchi, L. M. F., Coelho, V., Abel, L., Lopez, A. P., Oshiro, S. E., Aliotti, S., Cunha-Neto, E., Pomerantzeff, P. M. A., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63415-3 · Cited by 213
Collier, P., Watson, C. J., Voon, V., Phelan, D., Jan, A., Mak, G., Martos, R., Baugh, J. A., Ledwidge, M. T., & McDonald, K. M. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr079 · Cited by 213
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
Van Tassell, B. W., Trankle, C. R., Canada, J. M., Carbone, S., Buckley, L., Kadariya, D., Del Buono, M. G., Billingsley, H., Wohlford, G., Viscusi, M., et al. (2018) · Circulation: Heart Failure · doi:10.1161/circheartfailure.118.005036 · Cited by 213
Li, R.-K., Li, G., Mickle, D. A. G., Weisel, R. D., Merante, F., Luss, H., Rao, V., Christakis, G. T., & Williams, W. G. (1997) · Circulation · doi:10.1161/01.cir.96.3.874 · Cited by 211
Elhage, R., Maret, A., Pieraggi, M.-T., Thiers, J. C., Arnal, J. F., & Bayard, F. (1998) · Circulation · doi:10.1161/01.cir.97.3.242 · Cited by 209
Valgimigli, M., Ceconi, C., Malagutti, P., Merli, E., Soukhomovskaia, O., Francolini, G., Cicchitelli, G., Olivares, A., Parrinello, G., Percoco, G., et al. (2005) · Circulation · doi:10.1161/01.cir.0000155614.35441.69 · Cited by 209
The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes
Anzai, A., Choi, J. L., He, S., Fenn, A. M., Nairz, M., Rattik, S., McAlpine, C. S., Mindur, J. E., Chan, C. T., Iwamoto, Y., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170689 · Cited by 209
Elliott, W. J. (2007) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2007.01.002 · Cited by 208
Tumor necrosis factor-alpha in human arterial wall with atherosclerosis
Rus, F. G., Niculescu, F., & Vlaicu, R. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90066-c · Cited by 207
Kamat, N. V., Thabet, S. R., Xiao, L., Saleh, M. A., Kirabo, A., Madhur, M. S., Delpire, E., Harrison, D. G., & McDonough, A. A. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04975 · Cited by 206
Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-α
Maekawa, N., Wada, H., Kanda, T., Niwa, T., Yamada, Y., Saito, K., Fujiwara, H., Sekikawa, K., & Seishima, M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01738-2 · Cited by 204
Palmer, J. N., Hartogensis, W. E., Patten, M., Fortuin, F. D., & Long, C. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117956 · Cited by 203
Norlander, A. E., Saleh, M. A., Kamat, N. V., Ko, B., Gnecco, J., Zhu, L., Dale, B. L., Iwakura, Y., Hoover, R. S., McDonough, A. A., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07493 · Cited by 201
MERHISOUSSI, F., KWAK, B., MAGNE, D., CHADJICHRISTOS, C., BERTI, M., PELLI, G., JAMES, R., MACH, F., & GABAY, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.008 · Cited by 200
Boekholdt, S. M., Peters, R. J. G., Hack, C. E., Day, N. E., Luben, R., Bingham, S. A., Wareham, N. J., Reitsma, P. H., & Khaw, K.-T. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000134294.54422.2e · Cited by 196
Loperena, R., Van Beusecum, J. P., Itani, H. A., Engel, N., Laroumanie, F., Xiao, L., Elijovich, F., Laffer, C. L., Gnecco, J. S., Noonan, J., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy112 · Cited by 187
Role of inflammatory signaling in atrial fibrillation
Scott, L., Li, N., & Dobrev, D. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.10.020 · Cited by 187
Tipping, P. G., & Hancock, W. W. (1993) · PubMed · Cited by 184
Kumar, S., Wang, G., Zheng, N., Cheng, W., Ouyang, K., Lin, H., Liao, Y., & Liu, J. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12267 · Cited by 184
THE ROLE OF TNF IN CARDIOVASCULAR DISEASE
FERRARI, R. (1999) · Pharmacological Research · doi:10.1006/phrs.1998.0463 · Cited by 182
The association of sudden cardiac death with inflammation and other traditional risk factors
Parekh, R. S., Plantinga, L. C., Kao, W. H. L., Meoni, L. A., Jaar, B. G., Fink, N. E., Powe, N. R., Coresh, J., & Klag, M. J. (2008) · Kidney International · doi:10.1038/ki.2008.449 · Cited by 181
Elevated Levels of Activin A in Heart Failure: Potential Role in Myocardial Remodeling
Yndestad, A., Ueland, T., Øie, E., Florholmen, G., Halvorsen, B., Attramadal, H., Simonsen, S., Frøland, S. S., Gullestad, L., Christensen, G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000120704.97934.41 · Cited by 180
Li, H., Freeman, M. W., & Libby, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117628 · Cited by 179
Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players
Saadat, S., Noureddini, M., Mahjoubin-Tehran, M., Nazemi, S., Shojaie, L., Aschner, M., Maleki, B., Abbasi-kolli, M., Rajabi Moghadam, H., Alani, B., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.588347 · Cited by 179
Shephard, P., Martin, G., Smola-Hess, S., Brunner, G., Krieg, T., & Smola, H. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63764-9 · Cited by 177
Accelerated Atherosclerosis in Mice Lacking Tumor Necrosis Factor Receptor p55
Schreyer, S. A., Peschon, J. J., & LeBoeuf, R. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26174 · Cited by 176
Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis
Ko, T., Nomura, S., Yamada, S., Fujita, K., Fujita, T., Satoh, M., Oka, C., Katoh, M., Ito, M., Katagiri, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30630-y · Cited by 174
Persistent Expression of Cytokine in the Chronic Stage of Viral Myocarditis in Mice
Shioi, T., Matsumori, A., & Sasayama, S. (1996) · Circulation · doi:10.1161/01.cir.94.11.2930 · Cited by 173
Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion
Gurevitch, J., Frolkis, I., Yuhas, Y., Paz, Y., Matsa, M., Mohr, R., & Yakirevich, V. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00105-2 · Cited by 170
Luther, J. M., Gainer, J. V., Murphey, L. J., Yu, C., Vaughan, D. E., Morrow, J. D., & Brown, N. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000248135.97380.76 · Cited by 169
Kuusisto, J., Kärjä, V., Sipola, P., Kholová, I., Peuhkurinen, K., Jääskeläinen, P., Naukkarinen, A., Ylä-Herttuala, S., Punnonen, K., & Laakso, M. (2012) · Heart · doi:10.1136/heartjnl-2011-300960 · Cited by 168
Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function
Mia, M. M., Cibi, D. M., Ghani, S. A. B. A., Singh, A., Tee, N., Viswanathan, S., Bogireddi, H., Cook, S. A., Mao, J., & Singh, M. K. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab205 · Cited by 168
Hilfiker-Kleiner, D., Shukla, P., Klein, G., Schaefer, A., Stapel, B., Hoch, M., Müller, W., Scherr, M., Theilmeier, G., Ernst, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.933127 · Cited by 167
Pathophysiology of essential hypertension: an update
Saxena, T., Ali, A. O., & Saxena, M. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1540301 · Cited by 166
TNF-α Contributes to Endothelial Dysfunction by Upregulating Arginase in Ischemia/Reperfusion Injury
Gao, X. J., Xu, X., Belmadani, S., Park, Y., Tang, Z., Feldman, A. M., Chilian, W. M., & Zhang, C. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142521 · Cited by 165
Interleukin-8 Production by Macrophages From Atheromatous Plaques
Apostolopoulos, J., Davenport, P., & Tipping, P. G. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.1007 · Cited by 165
Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
Shah, A. K., Bhullar, S. K., Elimban, V., & Dhalla, N. S. (2021) · Antioxidants · doi:10.3390/antiox10060931 · Cited by 165
Self-citationBracey, N. A., Gershkovich, B., Chun, J., Vilaysane, A., Meijndert, H. C., Wright, J. R., Fedak, P. W. M., Beck, P. L., Muruve, D. A., & Duff, H. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.550624 · Cited by 164
Aukrust, P., Gullestad, L., Ueland, T., Damås, J. K., & Yndestad, A. (2005) · Annals of Medicine · doi:10.1080/07853890510007232 · Cited by 164
Dalekos, G. Ν., Elisaf, M., Bairaktari, E. T., Tsolas, O., & Siamopoulos, K. C. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90178-5 · Cited by 164
A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?
Szekely, Y., & Arbel, Y. (2018) · Cardiology and Therapy · doi:10.1007/s40119-018-0104-3 · Cited by 164
Shioi, T., Matsumori, A., Kihara, Y., Inoko, M., Ono, K., Iwanaga, Y., Yamada, T., Iwasaki, A., Matsushima, K., & Sasayama, S. (1997) · Circulation Research · doi:10.1161/01.res.81.5.664 · Cited by 162
Kubota, T., Bounoutas, G. S., Miyagishima, M., Kadokami, T., Sanders, V. J., Bruton, C., Robbins, P. D., McTiernan, C. F., & Feldman, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.21.2518 · Cited by 160
Anti–Tumor Necrosis Factor-Alpha Improves Myocardial Recovery After Ischemia and Reperfusion
Gurevitch, J., Frolkis, I., Yuhas, Y., Lifschitz-Mercer, B., Berger, E., Paz, Y., Matsa, M., Kramer, A., & Mohr, R. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00328-8 · Cited by 160
Evidence for altered interleukin (IL)‐18 pathway in human heart failure
Mallat, Z., Heymes, C., Corbaz, A., Logeart, D., Alouani, S., Solal, A. C., Seidler, T., Hasenfuss, G. P., Chvatchko, Y., Shah, A. M., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2426fje · Cited by 160
Arbustini, E., Grasso, M., Diegoli, M., Pucci, A., Bramerio, M., Ardissino, D., Angoli, L., de Servi, S., Bramucci, E., Mussini, A., et al. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90383-v · Cited by 160
Interleukin-6 signalling in health and disease
Rose-John, S. (2020) · F1000Research · doi:10.12688/f1000research.26058.1 · Cited by 159
Intracardiac and extracardiac markers of inflammation during atrial fibrillation
Marcus, G. M., Smith, L. M., Ordovas, K., Scheinman, M. M., Kim, A. M., Badhwar, N., Lee, R. J., Tseng, Z. H., Lee, B. K., & Olgin, J. E. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2009.10.004 · Cited by 158
Kishikawa, H., Shimokama, T., & Watanabe, T. (1993) · Virchows Archiv A Pathological Anatomy and Histopathology · doi:10.1007/bf01606532 · Cited by 158
Tumor Necrosis Factor-α Produced in the Kidney Contributes to Angiotensin II–dependent Hypertension
Zhang, J., Patel, M. B., Griffiths, R., Mao, A., Song, Y.-S., Karlovich, N. S., Sparks, M. A., Jin, H., Wu, M., Lin, E. E., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03863 · Cited by 158
Birger, M. L., Kaldjian, A. S., Roth, G. A., Moran, A. E., Dieleman, J. L., & Bellows, B. K. (2021) · Circulation · doi:10.1161/circulationaha.120.053216 · Cited by 158
Venegas‐Pont, M., Manigrasso, M. B., Grifoni, S. C., LaMarca, B. B., Maric, C., Racusen, L. C., Glover, P. H., Jones, A. R., Drummond, H. A., & Ryan, M. J. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157685 · Cited by 156
Eghbali, M., Tomek, R. M., Woods, C., & Bhambi, B. K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.795 · Cited by 154
Cardiac fibroblasts influence cardiomyocyte phenotype in vitro
LaFramboise, W. A., Scalise, D., Stoodley, P., Graner, S. R., Guthrie, R. D., Magovern, J. A., & Becich, M. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00166.2006 · Cited by 153
Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation
Saleh, M. A., McMaster, W. G., Wu, J., Norlander, A. E., Funt, S. A., Thabet, S., Kirabo, A., Xiao, L., Chen, W., Itani, H. A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76327 · Cited by 153
Honsho, S., Nishikawa, S., Amano, K., Zen, K., Adachi, Y., Kishita, E., Matsui, A., Katsume, A., Yamaguchi, S., Nishikawa, K., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.208199 · Cited by 149
TNF-α inhibition reduces renal injury in DOCA-salt hypertensive rats
Elmarakby, A. A., Quigley, J. E., Imig, J. D., Pollock, J. S., & Pollock, D. M. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00466.2007 · Cited by 149
Pro‐inflammatory cytokines in patients with essential hypertension
Peeters, A. C. T. M., Netea, M. G., Janssen, M. C. H., Kullberg, B. J., van der Meer, J. W. M., & Thien, T. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00743.x · Cited by 147
Devlin, C. M., Kuriakose, G., Hirsch, E., & Tabas, I. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092324399 · Cited by 147
Effects of Interleukin 17 on the cardiovascular system
Robert, M., & Miossec, P. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.009 · Cited by 147
Coles, B., Fielding, C., Rose-John, S., Scheller, J., Jones, S. A., & O'Donnell, V. (2007) · American Journal of Pathology · doi:10.2353/ajpath.2007.061078 · Cited by 143
T-Cell Mineralocorticoid Receptor Controls Blood Pressure by Regulating Interferon-Gamma
Sun, X.-N., Li, C., Liu, Y., Du, L., Zeng, M., Zheng, X., Zhang, W.-C., Liu, Y., Zhu, M., Kong, D., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.310480 · Cited by 143
Xie, Z., Singh, M., & Singh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405844200 · Cited by 142
Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis.
Lane, J. R., Neumann, D. A., Lafond-Walker, A., Herskowitz, A., & Rose, N. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1682 · Cited by 141
Interleukin-18 mediates interleukin-1-induced cardiac dysfunction
Toldo, S. A., Mezzaroma, E., O’Brien, L. C., Marchetti, C., Seropian, I. M., Voelkel, N. F., Tassell, B. W. V., Dinarello, C. A., & Abbate, A. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2013 · Cited by 141
Cited by
Ussia, S., Ritorto, G., Mollace, R., Serra, M., Tavernese, A., Altomare, C., Muscoli, C., Fini, M., Barillà, F., Indolfi, C., et al. (2025) · Nutrients · doi:10.3390/nu17111843 · Cited by 28
Metadata
- Authors
- Zhang, H., & Dhalla, N. S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-01-16
- Volume
- 25
- Issue
- 2
- Pages
- 1082
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4390960144
- Cited by
- 385
- References
- 360
- FWCI
- 103.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.